Niraparib: A Poly(ADP-ribose) Polymerase (PARP) Inhibitor for the Treatment of Tumors with Defective Homologous Recombination - IRBM

Niraparib: A Poly(ADP-ribose) Polymerase (PARP) Inhibitor for the Treatment of Tumors with Defective Homologous Recombination

By Philip Jones, Keith Wilcoxen, Michael Rowley, and Carlo Toniatti

Journal of Medicinal Chemistry 2015 58 (8), 3302-3314

DOI: 10.1021/jm5018237

Back to news listing

IRBM IN THE NEWS

PRESS RELEASES

EVENTS